Long View (41RB112): Data Recovery of Two Plains Village Period Components in Roberts County, Texas, Volume 1

This archeological data recovery investigation in Roberts County in the northeastern panhandle of Texas was necessitated by the proposed widening of State Highway 70 (CSJ: 0490-04-037) by the Texas Department of Transportation (TxDOT), Amarillo District. This proposed highway rehabilitation program will directly impact a roughly 10 meter (m, 30 ft.) wide north-south section of prehistoric site 41RB112, the Long View site. This site consists of two horizontally distinct Plains Village period occupations shallowly buried along a linear interfluvial ridge between two small tributary creeks to the Canadian River in the midslope of this broad, dissected valley. This site was initially discovered by TxDOT archeologist, Dennis Price in June 2004 during an archeological inventory of the proposed 9.7 kilometer (6 mile) section north of the Canadian River in response to the planned highway rehabilitation program. Based on Mr. Price’s discovery of multiple artifact classes in buried context he recommended this site be assessed for its eligibility for listing on the National Register of Historic Places under criterion d and possible designation as a State Archeological Landmark (SAL) per the requirements of Section 106 of the National Historic Preservation Act (NHPA) and other related legislation. Following the Texas Historical Commissions concurrence with that recommendation, TxDOT through the Environmental (ENV) Affairs Division, contracted to TRC Environmental Corporation (TRC) under an existing Scientific Services Contract No. 57XXSA006 and issued a Work Authorization to TRC of Austin to conduct the site eligibility assessment. During a site visit by TxDOT geoarcheologist James Abbott and TRC archeologist Mike Quigg in February 2005, the site boundaries were expanded to nearly 300 meters (m) along the proposed area of potential effect (APE). Investigative strategies were devised to assess the Long View site. In May 2005, TRC’s archeologists from Austin conducted archeological testing for a NRHP and SAL eligibility assessment investigation at 41RB112. The assessment along the 10-m-wide by 300-m-long APE was accomplished by hand-excavating 28 1-by-1 m units (totaling 16.8 m3), hand-excavating four narrow ca. 30 centimeter (cm) wide trenches (two in each area totaling nearly 32 linear meters), as well as cleaning and inspecting 28 m of existing road cut exposures. These investigations determined that cultural materials clustered at the northern and southern ends (Areas A and C respectively) of the site with nearly 120 m of noncultural bearing deposits (Area B) between the two concentrations. A 4-m-wide mechanically bladed fireguard paralleled the existing fenceline throughout the length of the APE and disturbed much of the near surface materials in that zone. The opposite, eastern side of the highway was investigated through the excavation of six 50-by-50 cm shovel tests, surface, and road cut inspection. Based on the results from the hand-excavations and various collections conducted during the site assessment, it became apparent that the two ends (Areas A and C) of the Long View site in TxDOT’s proposed APE contained well-defined cultural components in the top 50 cmbs. Each end appeared to represent habitation remains from single occupation episodes with potential structures, restricted to a narrow time period of less than 100 years between uncalibrated 630 and 710 B.P. of the Plains Village period. Rodent and natural disturbances had vertically displaced some small cultural objects within the sandy deposits, but the restricted period of occupation to roughly a 100 year period reduces this impact. TRC recommended the site was eligible for listing on the National Register and as a State Landmark. The Texas Historical Commissions concurred with that recommendation, and subsequently the ENV Affairs Division of TxDOT, again contracted to TRC under an existing Scientific Services Contract No. 575XXSA008 and issued a Work Authorization to TRC Austin to perform the mitigation of the proposed impacts. Data recovery investigations were conducted during August through November 2006 along the western side of the existing highway. The previously identified northern-Area A and southern–Area C areas with high concentrations of cultural materials were targeted. These investigations began with a thorough geophysical survey that employed three noninvasive electrical detective instruments across Areas A and C anticipating to detect the locations of subsurface cultural features to target by hand-excavations. Some excavations targeted the detected anomalies, whereas others targeted previously identified features. In the end, hand-excavated blocks were completed in Areas A and C. The excavations totaled 128 m2 in Area A and 93 m2 in Area C for a grand total of 221 m2 or 103.4 m3. In conjunction with the archeological excavations, geoarcheological investigations focused on defining the age and development of the natural Holocene sediments that contained the cultural materials. The geoarcheological assessment included detailed stratigraphic documentation of site and near site deposits, sediment texture characterization, soil thin sections, magnetic susceptibility, multiple chemical analyses (organic, calcium, and phosphorus). Detailed stratigraphic data was also collected at two rare pithouse structures to pursue construction and filling episodes. The excavations yielded significant and diverse cultural assemblages from the two occupations assigned Component A and C. Both components are attributed to the Plains Village period with two discrete occupations dating to uncalibrated 460 to 535 B.P. (cal A.D. 1398 to 1447) in Component A and 530 to 700 B.P. (cal A.D. 1280 to 1437) in Component C. The two assemblages are significant not only in their diversity and quality of materials but also in the information they yielded. This report represents one of the first complete documents to present the entire cultural assemblage from a single site for this time period and region. The total recovered assemblage includes 157 formal chipped and ground stone tools, 226 informal tools, 3,414 pieces of lithic debitage, over 6,400 faunal fragments (1.4 kg), some 1,541 ceramic sherds, 1,790 burned rocks, at least 116 macrobotanical samples that includes 16 maize cobs, two human burials, and remains of a third, juvenile scattered along a previously bladed fireguard, 32 intact cultural features that include two rare pithouses, and other cultural debris related to these two campsites. The human remains and associated artifacts will be repatriated in accord with the requirements of the Native American Graves Protection and Repatriation Act (NAGPRA). A suite of 10 technical analyses directed at mostly the cultural assemblages included; use-wear, phytolith, diatom, petrography, macrobotanical, starch grain, instrumental neutron activation, bison bone isotopes, obsidian sourcing, radiocarbon and optical stimulated dating. This data was used to address 11 specific research questions concerning these Plains Village period occupations. Not only does the cultural debris contribute to our understanding of the time period but the geoarcheological information obtained explains the conditions and how the materials were preserved, and inform us concerning the past depositional environment in this immediate area. The combined information contributes to a significant understanding to a specific part of the Plains Village cultures in the Texas panhandle. Following the acceptance of the final report by the TxDOT and the Texas Historical Commission these cultural materials and all the documentation from the combined investigations will be permanently curated at Texas State University in San Marcos, Texas. The curated materials will provide important data that can be researched by interested parties in the future

Acid-dissolution of antigorite, chrysotile and lizardite for ex situ carbon capture and storage by mineralisation

Serpentine minerals serve as a Mg donor in carbon capture and storage by mineralisation (CCSM). The acid-treatment of nine comprehensively-examined serpentine polymorphs and polytypes, and the subsequent microanalysis of their post-test residues highlighted several aspects of great importance to the choice of the optimal feed material for CCSM. Compelling evidence for the non-uniformity of serpentine mineral performance was revealed, and the following order of increasing Mg extraction efficiency after three hours of acid-leaching was established: Al-bearing polygonal serpentine (<5%) ≤ Al-bearing lizardite 1T (≈5%) < antigorite (24-29%) < well-ordered lizardite 2H1 (≈65%) ≤ Al-poor lizardite 1T (≈68%) < chrysotile (≈70%) < poorly-ordered lizardite 2H1 (≈80%) < nanotubular chrysotile (≈85%). It was recognised that the Mg extraction efficiency of the minerals depended greatly on the intrinsic properties of crystal structure, chemistry and rock microtexture. On this basis, antigorite and Al-bearing well-ordered lizardite were rejected as potential feedstock material whereas any chrysotile, non-aluminous, widely spaced lizardite and/or disordered serpentine were recommended. The formation of peripheral siliceous layers, tens of microns thick, was not universal and depended greatly upon the intrinsic microtexture of the leached particles. This study provides the first comprehensive investigation of nine, carefully-selected serpentine minerals, covering most varieties and polytypes, under the same experimental conditions. We focused on material characterisation and the identification of the intrinsic properties of the minerals that affect particle’s reactivity. It can therefore serve as a generic basis for any acid-based CCSM pre-treatment

Genome and Plasmid Sequences of Escherichia coli KV7, an Extended-Spectrum β-Lactamase Isolate Derived from Feces of a Healthy Pig.

We present single-contig assemblies for Escherichia coli strain KV7 (serotype O27, phylogenetic group D) and its six plasmids, isolated from a healthy pig, as determined by PacBio RS II and Illumina MiSeq sequencing. The chromosome of 4,997,475 bp and G+C content of 50.75% harbored 4,540 protein-encoding genes

Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status

AbstractBackgroundMany patients with asthma remain symptomatic despite treatment with inhaled corticosteroids (ICS) with or without long-acting β2-agonists (LABAs). Tiotropium add-on to ICS plus a LABA has been shown to improve lung function and reduce exacerbation risk in patients with symptomatic asthma.ObjectiveTo determine whether the efficacy of tiotropium add-on therapy is dependent on patients’ baseline characteristics.MethodsTwo randomized, double-blind, parallel-group, twin trials (NCT00772538 and NCT00776984) of once-daily tiotropium Respimat® 5 μg add-on to ICS plus a LABA were performed in parallel in patients with severe symptomatic asthma. Exploratory subgroup analyses of peak forced expiratory volume in 1 s (FEV1), trough FEV1, time to first severe exacerbation, time to first episode of asthma worsening, and seven-question Asthma Control Questionnaire responder rate were performed to determine whether results were influenced by baseline characteristics.Results912 patients were randomized: 456 received tiotropium and 456 received placebo. Tiotropium improved lung function, reduced the risk of asthma exacerbations and asthma worsening, and improved asthma symptom control, compared with placebo, independent of baseline characteristics including gender, age, body mass index, disease duration, age at asthma onset, and FEV1 % predicted at screening and reversibility.ConclusionOnce-daily tiotropium 5 μg compared with placebo improved lung function, reduced the risk of asthma exacerbations and asthma worsening, and improved asthma symptom control, independent of a broad range of baseline characteristics, as add-on to ICS plus LABAs in patients with severe symptomatic asthma.Trial registryClinicalTrials.gov; numbers NCT00772538 and NCT00776984 URL: www.clinicaltrials.gov

Lecanemab in patients with early Alzheimer\u27s disease: Detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study

BACKGROUND: Lecanemab, a humanized IgG1 monoclonal antibody that targets soluble aggregated Aβ species (protofibrils), has demonstrated robust brain fibrillar amyloid reduction and slowing of clinical decline in early AD. The objective of this analysis is to report results from study 201 blinded period (core), the open-label extension (OLE), and gap period (between core and OLE) supporting the effectiveness of lecanemab. METHODS: The lecanemab study 201 core was a double-blind, randomized, placebo-controlled study of 856 patients randomized to one of five dose regimens or placebo. An OLE of study 201 was initiated to allow patients to receive open-label lecanemab 10mg/kg biweekly for up to 24 months, with an intervening off-treatment period (gap period) ranging from 9 to 59 months (mean 24 months). RESULTS: At 12 and 18 months of treatment in the core, lecanemab 10 mg/kg biweekly demonstrated dose-dependent reductions of brain amyloid measured PET and corresponding changes in plasma biomarkers and slowing of cognitive decline. The rates of clinical progression during the gap were similar in lecanemab and placebo subjects, with clinical treatment differences maintained after discontinued dosing over an average of 24 months in the gap period. During the gap, plasma Aβ42/40 ratio and p-tau181 levels began to return towards pre-randomization levels more quickly than amyloid PET. At OLE baseline, treatment differences vs placebo at 18 months in the randomized period were maintained across 3 clinical assessments. In the OLE, lecanemab 10 mg/kg biweekly treatment produced dose-dependent reductions in amyloid PET SUVr, improvements in plasma Aβ42/40 ratio, and reductions in plasma p-tau181. CONCLUSIONS: Lecanemab treatment resulted in significant reduction in amyloid plaques and a slowing of clinical decline. Data indicate that rapid and pronounced amyloid reduction correlates with clinical benefit and potential disease-modifying effects, as well as the potential to use plasma biomarkers to monitor for lecanemab treatment effects. TRIAL REGISTRATION: ClinicalTrials.gov NCT01767311

The intervertebral disc contains intrinsic circadian clocks that are regulated by age and cytokines and linked to degeneration

ObjectivesThe circadian clocks are internal timing mechanisms that drive ∼24-hour rhythms in a tissue-specific manner. Many aspects of the physiology of the intervertebral disc (IVD) show clear diurnal rhythms. However, it is unknown whether IVD tissue contains functional circadian clocks and if so, how their dysregulation is implicated in IVD degeneration.MethodsClock gene dynamics in ex vivo IVD explants (from PER2:: luciferase (LUC) reporter mice) and human disc cells (transduced with lentivirus containingPer2::luc reporters) were monitored in real time by bioluminescence photon counting and imaging. Temporal gene expression changes were studied by RNAseq and quantitative reverse transcription (qRT)-PCR. IVD pathology was evaluated by histology in a mouse model with tissue-specific deletion of the core clock geneBmal1.ResultsHere we show the existence of the circadian rhythm in mouse IVD tissue and human disc cells. This rhythm is dampened with ageing in mice and can be abolished by treatment with interleukin-1β but not tumour necrosis factor α. Time-series RNAseq revealed 607 genes with 24-hour patterns of expression representing several essential pathways in IVD physiology. Mice with conditional knockout ofBmal1in their disc cells demonstrated age-related degeneration of IVDs.ConclusionsWe have established autonomous circadian clocks in mouse and human IVD cells which respond to age and cytokines, and control key pathways involved in the homeostasis of IVDs. Genetic disruption to the mouse IVD molecular clock predisposes to IVD degeneration. These results support the concept that disruptions to circadian rhythms may be a risk factor for degenerative IVD disease and low back pain.</jats:sec

Revolutionizing Alzheimer\u27s disease and clinical trials through biomarkers

AbstractThe Alzheimer's Association's Research Roundtable met in May 2014 to explore recent progress in developing biomarkers to improve understanding of disease pathogenesis and expedite drug development. Although existing biomarkers have proved extremely useful for enrichment of subjects in clinical trials, there is a clear need to develop novel biomarkers that are minimally invasive and that more broadly characterize underlying pathogenic mechanisms, including neurodegeneration, neuroinflammation, and synaptic dysfunction. These may include blood-based assays and new neuropsychological testing protocols, as well as novel ligands for positron emission tomography imaging, and advanced magnetic resonance imaging methodologies. In addition, there is a need for biomarkers that can serve as theragnostic markers of response to treatment. Standardization remains a challenge, although international consortia have made substantial progress in this area and provide lessons for future standardization efforts

The Warden Attitude: An investigation of the value of interaction with everyday wildlife

Using a discrete choice experiment, we elicit valuations of engagement with ‘everyday wildlife’ through feeding garden birds. We find that bird-feeding is primarily but not exclusively motivated by the direct consumption value of interaction with wildlife. The implicit valuations given to different species suggest that people prefer birds that have aesthetic appeal and that evoke human feelings of protectiveness. These findings suggest that people derive wellbeing by adopting a warden-like role towards ‘their’ wildlife. We test for external validity by conducting a hedonic analysis of sales of bird food. We discuss some policy implications of the existence of warden attitudes